By Professor David Lawson Morris

Journal articles

Chua TC; Liauw W; Zhao J; Morris DL, 2011, 'Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate', Annals of Surgery, 253, pp. 769 - 773, http://dx.doi.org/10.1097/SLA.0b013e31820b4dba

Chua TC; Crowe PJ; Morris DL, 2011, 'Whither surgical oncology?', ANZ Journal of Surgery, 81, pp. 763 - 764, http://dx.doi.org/10.1111/j.1445-2197.2011.05875.x

Morris DL; Roberts AL; Witherden AS; Tarzi R; Barros P; Whittaker JC; Cook TH; Aitman TJ; Vyse TJ, 2010, 'Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus', European Journal of Human Genetics, 18, pp. 1027 - 1031, http://dx.doi.org/10.1038/ejhg.2010.56

Yan TD; Sugarbaker PH; Elias D; Glehen O; Levine EA; Moran BJ; Deraco M; Morris DL; Piso P, 2010, 'Reply to M. Markman', Journal of Clinical Oncology, 28, http://dx.doi.org/10.1200/JCO.2010.29.1138

Cao C; Yan TD; Morris DL; Bester L, 2010, 'Radioembolization with Yttrium-90 Microspheres for Pancreatic Cancer Liver Metastases: Results from a Pilot Study', Tumori Journal, 96, pp. 955 - 958, http://dx.doi.org/10.1700/548.6515

Saxena A; Yan TD; Morris DL, 2010, 'Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures', European Journal of Surgical Oncology, 36, pp. 309 - 314, http://dx.doi.org/10.1016/j.ejso.2009.06.008

Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.1007/s00280-009-1157-8

Feehally J; Farrall M; Boland A; Gale DP; Gut I; Heath S; Kumar A; Peden JF; Maxwell PH; Morris DL; Padmanabhan S; Vyse TJ; Zawadzka A; Rees AJ; Lathrop M; Ratcliffe PJ, 2010, 'HLA has strongest association with IgA nephropathy in genome-wide analysis', Journal of the American Society of Nephrology, 21, pp. 1791 - 1797, http://dx.doi.org/10.1681/ASN.2010010076

Saxena A; Yan TD; Morris DL, 2010, 'A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis', World Journal of Surgery, 34, pp. 70 - 78, http://dx.doi.org/10.1007/s00268-009-0206-0

Esquivel J; Chua TC; Stojadinovic A; Melero JT; Levine E; Gutman M; Howard R; Piso P; Nissan A; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Shen P; Stewart J; Sugarbaker PH; Barone R; Hoefer R; Morris DL; Sardi A; Sticca R, 2010, 'Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi-institutional study', Journal of Surgical Oncology, 102, pp. 565 - 570, http://dx.doi.org/10.1002/jso.21601

Pourgholami MH; Khachigian LM; Fahmy R; Badar S; Wang L; Chu SW; Morris DL, 2010, 'Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis', Biochemical and Biophysical Research Communications, 397, pp. 729 - 734, http://dx.doi.org/10.1016/j.bbrc.2010.06.019

Saxena A; Chua TC; Sarkar A; Chu F; Morris DL, 2010, 'Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic reseciton of intrahepatic cholangiocarcinoma: A 19-year experience from an Established Australian Hepatobiliary Unit', Journal of Gastrointestinal Surgery, 14, pp. 1128 - 1138, http://dx.doi.org/10.1007/s11605-010-1203-1

Chua TC; Saxena A; Chu F; Liauw WS; Zhao J; Morris DL, 2010, 'Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients - Experience from an Australian Hepatobiliary Unit', Journal of Gastrointestinal Surgery, 14, pp. 1370 - 1380, http://dx.doi.org/10.1007/s11605-010-1277-9

Saxena A; Yan TD; Morris DL, 2010, 'Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures', European Journal of Surgical Oncology, 36, pp. 309 - 314, http://dx.doi.org/10.1016/j-ejso.2009.06.008

Saxena A; Yan TD; Chua TC; Morris DL, 2010, 'Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei', Annals of Surgical Oncology, 17, pp. 1291 - 1301, http://dx.doi.org/10.1245/s10434-009-0875-9

Zhao Y; Pourgholami MH; Morris DL; Collins JG; Day AI, 2010, 'Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril', Organic and Biomolecular Chemistry, 8, pp. 3328 - 3337, http://dx.doi.org/10.1039/c003732j

Pelz J; Chua TC; Esquivel J; Stojadinovic A; Doerfer J; Morris DL; Maeder U; Germer CT; Kerscher A, 2010, 'Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.', BMC Cancer, 10:689, pp. 1 - 12, http://dx.doi.org/10.1186/1471-2407-10-689

Chua TC; Martin S; Saxena A; Liauw WS; Yan TD; Zhao J; Lok I; Morris DL, 2010, 'Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (Peritonectomy) at the St George Hospital peritoneal surface malignancy program', Annals of Surgery, 251, pp. 323 - 329, http://dx.doi.org/10.1097/SLA.0b013e3181c9b53c

Chua TC; Glenn DW; Morris DL, 2010, 'Extending the survival of patients with melanoma lung metastases through radiofrequency ablation', ACTA Oncologica, 49, pp. 517 - 519, http://dx.doi.org/10.3109/02841860903473305

Saxena A; Chua TC; Bester L; Kokandi A; Morris DL, 2010, 'Factors predicting response and survival after Yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: A critical appraisal of 48 cases', Annals of Surgery, 251, pp. 910 - 916, http://dx.doi.org/10.1097/SLA.0b013e3181d3d24a

Yao P; Stanton R; Chua TC; Wines MP; Gunasegaram A; Ladd LA; Morris DL, 2010, 'Hand-assisted laparoscopic partial nephrectomy: A controlled study of bipolar InLine radiofrequency ablation device in swine', Surgical Innovation, 17, pp. 57 - 62, http://dx.doi.org/10.1177/1553350609360354

Ding JH; Chua TC; Al-Mohaimeed K; Morris DL, 2010, 'Hepatocellular carcinoma peritoneal metastases: Report of three cases and collective review of the literature', Annals of Academy of Medicine Singapore, 39, pp. 734 - 737

Chua TC; Morris DL; Esquivel J, 2010, 'Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy', Annals of Surgical Oncology, 17, pp. 1330 - 1336, http://dx.doi.org/10.1245/s10434-009-0866-x

Chua TC; Yao P; Akhter J; Morris DL, 2010, 'Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy', Pathology and Oncology Research, 16, pp. 217 - 222, http://dx.doi.org/10.1007/s12253-009-9210-9

Chua TC; Chu F; Butler P; Quinn RJ; Glenn DW; Liauw WS; Morris DL, 2010, 'Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma', Cancer, 116, pp. 4069 - 4077, http://dx.doi.org/10.1002/cncr.25283

Chua TC; Sarkar A; Saxena A; Glenn DW; Zhao J; Morris DL, 2010, 'Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.', Annals of Oncology, 21, pp. 2017 - 2022, http://dx.doi.org/10.1093/annonc/mdq098

Chua TC; Saxena A; Schellekens J; Liauw WS; Yan TD; Fransi S; Zhao J; Morris DL, 2010, 'Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: Towards a new perspective of this treatment.', Annals of Surgical Oncology, 251, pp. 101 - 106, http://dx.doi.org/10.1097/SLA.0b013e3181b5ae43

Mekkawy AH; De Bock CE; Lin Z; Morris DL; Wang Y; Pourgholami MH, 2010, 'Novel protein interactors of urokinase-type plasminogen activator receptor', Biochemical and Biophysical Research Communications, 399, pp. 738 - 743, http://dx.doi.org/10.1016/j.bbrc.2010.08.010

Chua TC; Yan TD; Zhao J; Morris DL, 2010, 'Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy', American Journal of Clinical Oncology - Cancer Clinical Trials, 33, pp. 568 - 571, http://dx.doi.org/10.1097/COC.0b013e3181b9cf47

Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.107/s00280-009-1157-8

Saxena A; Chua TC; Yan TD; Morris DL, 2010, 'Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: Incidence, risk factors, management, and clinical sequelae', Annals of Surgical Oncology, 17, pp. 1302 - 1310, http://dx.doi.org/10.1245/s10434-009-0898-2

Pourgholami MH; Cai YZ; Badar S; Wangoo K; Poruchynsky MS; Morris DL, 2010, 'Potent inhibition of tumoral hypoxia-inducible factor 1á by albendazole.', BMC Cancer, 10:143, pp. 1 - 7, http://dx.doi.org/10.1186/1471-2407-10-143

Cao C; Yan TD; Bester L; Liauw WS; Morris DL, 2010, 'Radioembolization with yttrium micropheres for neuroendocrine tumour liver metastases', British Journal of Surgery, 97, pp. 537 - 543, http://dx.doi.org/10.1002/bjs.6931

Cao C; Yan TD; Morris DL; Bester L, 2010, 'Radioembolization with yttrium-90 microspheres for pancreatic cancer liver metastases: results from a pilot study', Tumori, 96, pp. 955 - 958

Chua TC; Thornbury K; Saxena A; Liauw WS; Glenn DW; Zhao J; Morris DL, 2010, 'Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases', Cancer, 116, pp. 2106 - 2114, http://dx.doi.org/10.1002/cncr.24952

Tudor E; Chua TC; Liauw WS; Morris DL, 2010, 'Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma.', American Surgeon, 76, pp. 400 - 405

Chua TC; Robertson G; Liauw WS; Morris DL, 2010, 'Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: A last chance or futile efforts?', Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, pp. 478 - 484, http://dx.doi.org/10.1111/j.1479-828X.2010.01201.x

Chua TC; Liauw WS; Robertson G; Morris DL, 2010, 'Second-line treatment of first relapse recurrent ovarian cancer', Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, pp. 465 - 471, http://dx.doi.org/10.1111/j.1479-828X.2010.01209.x

Chua TC; Al-Zahrani A; Saxena A; Liauw WS; Zhao J; Morris DL, 2010, 'Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: A study of timing and the impact of malignant dedifferentiation.', Journal of the American College of Surgeons, 211, pp. 526 - 535, http://dx.doi.org/10.1016/j.jamcollsurg.2010.06.011

Chua TC; Bester L; Akhter J; Morris DL, 2010, 'Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres (R)) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.', Anticancer Research, 30, pp. 3005 - 3008

Chua TC; Saxena A; Morris DL, 2010, 'Surgical metastasectomy in AJCC stage IV M1c melanoma patients with gastrointestinal and liver metastases', Annals of Academy of Medicine Singapore, 39, pp. 634 - 639

evans KJ; Richardson M; Pavlakis N; Morris DL; Liauw WS; Bester L, 2010, 'Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres', Journal of Vascular and Interventional Radiology, 21, pp. 1521 - 1526, http://dx.doi.org/10.1016/j.jvir.2010.06.018

Chua TC; Liauw WS; Saxena A; Chu F; Glenn DW; Chai A; Morris DL, 2010, 'Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma', Liver International, 30, pp. 166 - 174, http://dx.doi.org/10.1111/j.1478-3231.2009.02166.x

Chua TC; Saxena A; Liauw WS; Kokandi A; Morris DL, 2010, 'Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases', Annals of Surgical Oncology, 17, pp. 492 - 501, http://dx.doi.org/10.1245/s10434-009-0781-1

Pourgholami MH; Cai YZ; Chu SW; Galettis P; Morris DL, 2010, 'The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.', Anticancer Research, 30, pp. 423 - 428

Morris DL; Chua TC, 2010, 'Treatments and outcomes of peritoneal surface tumors through a Centralized National Service (United Kingdom)', Diseases of the Colon and Rectum, 53, pp. 1218 - 1219, http://dx.doi.org/10.1007/DCR.0b013e318e28bcf

Saxena A; Bester L; Chua TC; Chu F; Morris DL, 2010, 'Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option', Annals of Surgical Oncology, 17, pp. 484 - 491, http://dx.doi.org/10.1245/s10434-009-0777-x

Shehata M; Yan K; Itoh S; King J; Glenn D; Quinn R; Morris DL, 2009, 'Splenomegaly and tumor marker response following selective internal radiation therapy for non-resectable liver metastases from neuroendocrine tumor', Dokkyo Journal of Medical Sciences, 36, pp. 131 - 134

Patyna S; Haznedar J; Morris D; Freshwater K; Peng G; Sukbuntherng J; Chmielewski G; Matsumoto D, 2009, 'Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits', Birth Defects Research Part B - Developmental and Reproductive Toxicology, 86, pp. 204 - 213, http://dx.doi.org/10.1002/bdrb.20194

Chua TC; Robertson G; Farrell R; Liauw W; Yan TD; Morris DL, 2009, 'Systematic review of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis: A more efficacious way of delivering intraperitoneal chemotherapy', Journal of Clinical Oncology, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5524

Back to profile page